The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
TRIDENT: A phase 2 study of relacorilant plus nab-paclitaxel and gemcitabine in patients with previously untreated metastatic pancreatic ductal adenocarcinoma.
 
Erkut Borazanci
Consulting or Advisory Role - Arcus Biosciences; Corcept Therapeutics; Merus; Revolution Medicines; VCN Biosciences
Research Funding - BioNTech (Inst); Biosplice (Inst); Bristol-Myers Squibb (Inst); Corcept Therapeutics (Inst); Daiichi Sankyo (Inst); Helix BioPharma (Inst); Idera (Inst); Lilly (Inst); Merck (Inst); Minneamrita Therapeutics (Inst); Pharmacyclics (Inst)
 
Drew Rasco
Research Funding - 23andMe (Inst); Adcentrx Therapeutics (Inst); Arcus Biosciences (Inst); AstraZeneca (Inst); Aulos Bioscience (Inst); Avenzo (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb/Celgene (Inst); Compugen (Inst); Context Therapeutics (Inst); Corcept Therapeutics (Inst); Cullinan Oncology (Inst); Eikon Therapeutics (Inst); Flare Therapeutics (Inst); FoRx Therapeutics (Inst); GlaxoSmithKline (Inst); Ipsen (Inst); Johnson & Johnson/Janssen (Inst); Macrogenics (Inst); MediLink Therapeutics (Inst); Multitude Therapeutics (Inst); OnCusp Therapeutics (Inst); PAQ Therapeutics (Inst); Plexium (Inst); PureTech (Inst); Rondo (Inst); Takeda (Inst); TD2 (Inst); Whitehawk (Inst); Whitehawk (Inst)
 
Anup Kasi
Consulting or Advisory Role - Cardinal Health; Ipsen; Partner Therapeutics
Research Funding - Ability Pharma (Inst); Boundless Bio (Inst); Cardiff Oncology (Inst); Cend Therapeutics (Inst); FibroGen (Inst); Geistlich Pharma (Inst); Medlink (Inst); Novita Pharmaceuticals (Inst); Novocure (Inst); Seattle Genetics/Astellas (Inst)
 
Davendra Sohal
Consulting or Advisory Role - AADi; AstraZeneca/MedImmune; Bayer; Elevar Therapeutics; Regeneron; Totus Medicines; TransThera Sciences (Nanjing), Inc.; Valar Labs
Speakers' Bureau - AstraZeneca; Incyte; Seagen
Research Funding - Ability Pharma (Inst); Amgen (Inst); Apexigen (Inst); Astellas Pharma (Inst); AstraZeneca/MedImmune (Inst); Bexion (Inst); Bristol-Myers Squibb (Inst); DualityBio (Inst); FibroGen (Inst); Genentech (Inst); Hengrui Therapeutics (Inst); Merck (Inst); Mirati Therapeutics (Inst); NextCure (Inst); Regeneron (Inst); Replimune (Inst); Roche (Inst); Triumvira Immunologics, Inc (Inst)
Travel, Accommodations, Expenses - Ability Pharma
 
Jesse Handler
Patents, Royalties, Other Intellectual Property - I am listed as a co-inventor on a provisional patent regarding the use of MetScore, a single sample scoring metric based on metastatic potential, for metastasis risk prediction in carcinomas.
 
Farshid Dayyani
Consulting or Advisory Role - AstraZeneca; Eisai; Jazz Pharmaceuticals
Speakers' Bureau - Astellas Pharma; beone; ipsen; Sirtex Medical; Takeda
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Exelixis (Inst); Genentech (Inst); Ipsen (Inst); Merck (Inst); Taiho Pharmaceutical (Inst)
 
Brian Grieb
Consulting or Advisory Role - Agenus; Lilly; Pfizer
Travel, Accommodations, Expenses - Agenus; Lilly
 
Richard Zuniga
Consulting or Advisory Role - Bristol Myers Squibb Foundation; Flatiron Health; Mirati Therapeutics; Takeda
Travel, Accommodations, Expenses - ChemoMouthpiece LLC
 
Lawrence Garbo
No Relationships to Disclose
 
Hristina Pashova
Employment - Corcept Therapeutics
Stock and Other Ownership Interests - Corcept Therapeutics
 
Priya Choudhry
Employment - Corcept Therapeutics
Stock and Other Ownership Interests - Corcept Therapeutics; United Health Group; Viking Therapeutics
Travel, Accommodations, Expenses - Corcept Therapeutics
 
Sachin Pai
Employment - Corcept Therapeutics Inc.; Erasca, Inc
Stock and Other Ownership Interests - Corcept Therapeutics Inc.; Erasca, Inc
 
Sreenivasa Chandana
Leadership - The Cancer & Hematology Centers
Consulting or Advisory Role - AstraZeneca; IPSEN; Novocure
Speakers' Bureau - Natera
Research Funding - Abbvie (Inst); Adcentrx Therapeutics (Inst); Amgen (Inst); Arvinas (Inst); AstraZeneca (Inst); BioNTech SE (Inst); BMS (Inst); Cardiff Oncology (Inst); Chugai Pharma (Inst); Corcept Therapeutics (Inst); Dicephera Pharmaceuticals, Inc. (Inst); Elevation Oncology (Inst); Exact Sciences (Inst); Exelixis (Inst); Genentech/Roche (Inst); Halda Therapeutics (Inst); IDEAYA Biosciences (Inst); IDEAYA Biosciences (Inst); IgM Biosciences (Inst); Incyte (Inst); Ipsen (Inst); Janssen (Inst); Johnson & Johnson/Janssen (Inst); Medlink (Inst); Merck (Inst); Mirati Therapeutics (Inst); Monte Rosa Therapeutics (Inst); Novocure (Inst); Pfizer (Inst); Qualigen Therapeutics (Inst); Rondo Therapeutics (Inst); Tizona Therapeutics, Inc. (Inst); Zymeworks (Inst)